ETON PHARMACEUTICALS INC. - COMMON STOCK

Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tablets, the First and Only FDA-Approved Generic Version of Carbaglu® (carglumic acid)

20 12 2021 07:30:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter Financial Results

15 11 2021 16:05:01 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE®

15 11 2021 06:30:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™ (topiramate) Oral Solution

08 11 2021 06:00:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021

03 11 2021 16:15:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Approved Orphan Drug Product Carglumic Acid

28 10 2021 07:30:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter Financial Results

16 8 2021 16:02:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

03 8 2021 16:05:02 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector

15 6 2021 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)

15 6 2021 10:37:52 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Dehydrated Alcohol Injection

28 5 2021 08:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Record Revenue and Earnings

13 5 2021 16:05:01 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021

04 5 2021 16:05:01 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors

17 3 2021 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results

16 3 2021 16:02:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16, 2021

04 3 2021 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference

16 2 2021 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Sale of Neurology Portfolio

08 2 2021 08:00:01 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE

14 1 2021 08:00:01 提供 Nasdaq GlobeNewswire